Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.384EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAQEWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.2.3.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.569EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.524EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.118EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.501EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.226EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.546EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.194EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.429.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.9 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.25.1.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.203EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.157EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.176EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.3.4 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.391EWon-ECACACAATCGATGCGCAGTA20502636526346R-2361.24South Korea
B.1.393EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.432EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.388EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.48EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.112EWon-ECACACAATCGATGCGCAGTA20502636526346R-8964.71South Korea
B.1.274EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.515EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.336EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.400.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.537EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.548EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.24.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.492EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.540EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.487EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.319EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.182EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.430EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.331EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-2308.74South Korea
AY.112.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.188EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.50EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
B.1.494EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used